AstraZeneca’s Tagrisso (Osimertinib) Secures the EC’s Approval to Treat Unresectable EGFR-Mutated Lung Cancer
Shots: Following the
Pfizer’s Braftovi (Encorafenib) Secures the US FDA’s Accelerated Approval as a 1L Treatment of BRAF V600E-Mutant Metastatic Colore...
Shots: The US FDA has granted accelerated approval to Braftovi + cetuximab & m...
Eli Lilly Reports the US FDA’s Approval of Zepbound (Tirzepatide) to Treat Moderate-to-Severe Obstructive Sleep Apnea in Obese Adu...
Shots: The US FDA has granted approval to Zepbound for treating moderate-to-severe...
Dong-A ST Receives EC Approval for Imuldosa (Biosimilar, Stelara)
Shots: Dong-A ST received EC approval for Imuldosa (DMB-3115), a biosimilar of Jan...
Lantern Pharma's LP-184 Gains the US FDA’s Fast-Track Designation to Treat TNBC
Shots: This designation is based on anti-tumor activity in 10 TNBC PDX models &...
Eli Lilly Reports Kinsula (Donanemab-Azbt) Approval in China to Treat Early Symptomatic Alzheimer's Disease
Shots: The NMPA has approved Kisunla (donanemab-azbt) based on
